MX2020009021A - Ensayos para detectar la presencia o la cantidad de un anticuerpo antifarmaco. - Google Patents

Ensayos para detectar la presencia o la cantidad de un anticuerpo antifarmaco.

Info

Publication number
MX2020009021A
MX2020009021A MX2020009021A MX2020009021A MX2020009021A MX 2020009021 A MX2020009021 A MX 2020009021A MX 2020009021 A MX2020009021 A MX 2020009021A MX 2020009021 A MX2020009021 A MX 2020009021A MX 2020009021 A MX2020009021 A MX 2020009021A
Authority
MX
Mexico
Prior art keywords
detecting
assays
amount
drug antibody
methods
Prior art date
Application number
MX2020009021A
Other languages
English (en)
Inventor
Susan Richards
Ryan Grabert
Valerie Theobald
Yuanxin Xu
Jad Zoghbi
Original Assignee
Genzyme Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genzyme Corp filed Critical Genzyme Corp
Publication of MX2020009021A publication Critical patent/MX2020009021A/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5306—Improving reaction conditions, e.g. reduction of non-specific binding, promotion of specific binding
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/537—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody
    • G01N33/539—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody involving precipitating reagent, e.g. ammonium sulfate
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2430/00—Assays, e.g. immunoassays or enzyme assays, involving synthetic organic compounds as analytes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Métodos y kits para detectar anticuerpos (por ejemplo, anticuerpos antifármaco). Estos métodos y kits permiten la detección, por ejemplo, de anticuerpos antifármaco en fluidos corporales humanos, tales como sangre, plasma y suero.
MX2020009021A 2014-02-11 2016-08-10 Ensayos para detectar la presencia o la cantidad de un anticuerpo antifarmaco. MX2020009021A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201461938556P 2014-02-11 2014-02-11

Publications (1)

Publication Number Publication Date
MX2020009021A true MX2020009021A (es) 2020-10-12

Family

ID=52684652

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2016010413A MX374652B (es) 2014-02-11 2015-02-11 Ensayos para detectar la presencia o la cantidad de un anticuerpo antifármaco.
MX2020009021A MX2020009021A (es) 2014-02-11 2016-08-10 Ensayos para detectar la presencia o la cantidad de un anticuerpo antifarmaco.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MX2016010413A MX374652B (es) 2014-02-11 2015-02-11 Ensayos para detectar la presencia o la cantidad de un anticuerpo antifármaco.

Country Status (19)

Country Link
US (4) US9759732B2 (es)
EP (5) EP4137816B1 (es)
CN (1) CN106164670B (es)
AU (2) AU2015217261B2 (es)
CA (1) CA2939080A1 (es)
CY (1) CY1121341T1 (es)
DK (1) DK3105592T3 (es)
ES (1) ES2705403T3 (es)
HR (1) HRP20190026T1 (es)
HU (1) HUE041669T2 (es)
LT (1) LT3105592T (es)
MX (2) MX374652B (es)
PL (1) PL3105592T3 (es)
PT (1) PT3105592T (es)
RS (1) RS58212B1 (es)
SG (2) SG11201606291VA (es)
SI (1) SI3105592T1 (es)
TR (1) TR201900160T4 (es)
WO (1) WO2015123315A1 (es)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4137816B1 (en) 2014-02-11 2025-03-19 Genzyme Corporation Assays for detecting the presence or amount of an anti-drug antibody
EP2982987A1 (en) * 2014-08-08 2016-02-10 Proteomika, S.L. Lateral flow immunoassays for the detection of antibodies against biological drugs
US9927443B2 (en) * 2015-04-10 2018-03-27 Conquerab Inc. Risk assessment for therapeutic drugs
AU2016337598B2 (en) * 2015-10-15 2022-10-13 Biocon Limited Method for detecting neutralizing antibodies against recombinant human insulin in human serum
WO2017102786A1 (en) * 2015-12-16 2017-06-22 F. Hoffmann-La Roche Ag Three-step acid dissociation enzyme linked immunosorbent (tadelis) assay
US9903866B2 (en) 2016-04-05 2018-02-27 Conquerab Inc. Portable devices for detection of antibodies against therapeutic drugs
EP3239711B1 (en) 2016-04-27 2019-12-25 JIMRO Co., Ltd. Method for measuring anti-drug antibody
US20200140565A1 (en) 2016-10-20 2020-05-07 I-Mab Novel cd47 monoclonal antibodies and uses thereof
CN110997727B (zh) * 2017-08-08 2025-03-18 豪夫迈·罗氏有限公司 用于确定微型猪样品中抗药物抗体的方法
JP7161534B2 (ja) 2017-11-29 2022-10-26 エフ．ホフマン－ラ ロシュ アーゲー 標的による干渉が抑制された抗薬物抗体アッセイ
CN109358192B (zh) * 2018-02-08 2020-05-12 中国科学院上海药物研究所 一种去除抗药抗体检测样品中游离药物的装置和方法、该装置的制备方法及应用
IL307286B2 (en) * 2018-04-11 2026-03-01 Regeneron Pharma Methods and compositions for quantifying il-33
BR112020022912A2 (pt) 2018-07-10 2021-02-23 Regeneron Pharmaceuticals, Inc. métodos para mitigar a interferência de alvo de fármaco em um imunoensaio de anticorpo antifármaco (ada)
JP7474240B2 (ja) * 2018-08-03 2024-04-24 ブリストル－マイヤーズ スクイブ カンパニー 抗薬物抗体を検出するための方法
US12105083B2 (en) * 2019-04-16 2024-10-01 Laboratory Corporation Of America Holdings Methods for detecting antibodies by surface plasmon resonance
KR102695013B1 (ko) 2019-04-24 2024-08-13 삼성전자주식회사 펠리클 조립체의 제조 방법 및 포토마스크 조립체의 제조 방법
JP7541534B2 (ja) * 2019-05-13 2024-08-28 リジェネロン・ファーマシューティカルズ・インコーポレイテッド 改善された競合的リガンド結合アッセイ
CN111982615A (zh) * 2019-05-23 2020-11-24 百奥泰生物制药股份有限公司 一种用于解离药物/ada复合物的解离液及其应用
CN112285351A (zh) * 2019-07-22 2021-01-29 上海益诺思生物技术股份有限公司 一种抗IgE单抗的ELISA检测方法
CA3148161A1 (en) * 2019-09-05 2021-03-11 Adverum Biotechnologies Anti-drug antibody assay
CN111171141A (zh) * 2020-01-20 2020-05-19 苏州药明康德新药开发有限公司 聚乙二醇在临床前安全性评价中的应用
CN111024958B (zh) * 2020-03-11 2020-06-23 同昕生物技术（北京）有限公司 用于检测单抗药物和抗单抗药物抗体的试剂及其应用
CA3180569A1 (en) * 2020-05-01 2021-11-04 Regeneron Pharmaceuticals, Inc. Neutralizing antibody assay for therapeutic proteins
JP7478040B2 (ja) * 2020-06-25 2024-05-02 シスメックス株式会社 Ａβペプチドの測定方法及びその方法に用いられる試薬組成物
CN116261662B (zh) * 2020-10-14 2024-05-31 天境生物科技(上海)有限公司 用于减轻输血前测定中治疗性抗cd47抗体的干扰的方法
US12435444B2 (en) 2021-03-09 2025-10-07 Cdr-Life Ag Rabbit-derived antigen binding protein nucleic acid libraries and methods of making the same
JP7062803B1 (ja) 2021-03-31 2022-05-06 積水メディカル株式会社 抗薬物抗体測定方法
CA3240046A1 (en) 2021-12-14 2023-06-22 Cdr-Life Ag Dual mhc-targeting t cell engager
CN114047343B (zh) * 2022-01-13 2022-05-31 美迪西普亚医药科技(上海)有限公司 双耐受型抗IgE单抗药物的免疫原性分析试剂盒及其使用方法和应用
WO2024052517A2 (en) 2022-09-09 2024-03-14 Bayer Aktiengesellschaft Medical use of ccr8 antibodies and dosing schedule
EP4587046A1 (en) 2022-09-14 2025-07-23 CDR-Life AG Mage-a4 peptide dual t cell engagers
CN120239821A (zh) * 2022-09-23 2025-07-01 默沙东有限责任公司 中和抗体测定方法
CN115561355B (zh) * 2022-09-26 2024-04-30 重庆迪纳利医药科技有限责任公司 羧肽酶g2的中和抗体检测方法以及基于lc-ms/ms的检测系统
CN116699147A (zh) * 2023-08-04 2023-09-05 军科正源（北京）药物研究有限责任公司 检测总IgE含量的方法以及相关试剂盒
CN117849327A (zh) * 2024-03-06 2024-04-09 军科正源（北京）药物研究有限责任公司 用于检测苏金单抗抗药性抗体的方法
WO2025213061A2 (en) 2024-04-04 2025-10-09 Ethyreal Bio, Inc. Anti-tshr antibodies and uses thereof
WO2025210181A1 (en) 2024-04-04 2025-10-09 Cdr-Life Ag Antigen binding proteins targeting an hla-restricted kk-lc-1 peptide
WO2025215160A1 (en) 2024-04-11 2025-10-16 Cdr-Life Ag Antigen binding proteins targeting an hla-restricted prame peptide
CN120761634B (zh) * 2025-09-02 2025-12-05 宁波熙宁检测技术有限公司 一种针对多特异性单克隆抗体药物的ada检测方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990006515A1 (en) * 1988-12-09 1990-06-14 Centocor, Inc. Anti-idiotopic immunometric assay
US5187065A (en) * 1989-12-22 1993-02-16 Schutzer Steven E Method and materials for detecting lyme disease
JP4902674B2 (ja) * 2006-03-09 2012-03-21 エフ．ホフマン−ラ ロシュ アーゲー 抗薬物抗体アッセイ法
EP2142925A1 (en) * 2007-05-07 2010-01-13 Wyeth a Corporation of the State of Delaware Elimination of interference in immunoassays caused by anti-carbohydrate antibodies
WO2009091240A1 (en) * 2008-01-15 2009-07-23 Stichting Sanquin Bloedvoorziening Method and kits for detecting antibodies against therapeutic antibodies
JP2010078374A (ja) 2008-09-24 2010-04-08 Olympus Corp 抗赤血球抗体の検出方法
US7799532B2 (en) * 2008-11-12 2010-09-21 Hemopet Detection and measurement of thyroid hormone autoantibodies
MX343327B (es) 2011-02-17 2016-11-01 Nestec Sa Ensayos para detectar autoanticuerpos contra farmacos anti-tnfa.
MX352118B (es) * 2012-03-08 2017-11-09 Hoffmann La Roche Metodo de inmunoanalisis cromatografico multiplexado para la caracterizacion de inmunocomplejos circulantes.
JP6563910B2 (ja) * 2013-07-04 2019-08-21 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ 血清サンプル中の抗薬物抗体を検出するための干渉抑制イムノアッセイ
EP4137816B1 (en) 2014-02-11 2025-03-19 Genzyme Corporation Assays for detecting the presence or amount of an anti-drug antibody

Also Published As

Publication number Publication date
EP4582812A2 (en) 2025-07-09
SG11201606291VA (en) 2016-08-30
EP3667321B1 (en) 2022-07-27
EP4137816B1 (en) 2025-03-19
MX374652B (es) 2025-03-06
HRP20190026T1 (hr) 2019-02-22
AU2015217261A1 (en) 2016-09-08
EP4137816A1 (en) 2023-02-22
AU2015217261B2 (en) 2020-08-27
DK3105592T3 (en) 2019-02-04
PT3105592T (pt) 2019-01-23
EP3422001A1 (en) 2019-01-02
US9759732B2 (en) 2017-09-12
TR201900160T4 (tr) 2019-02-21
ES2705403T3 (es) 2019-03-25
AU2020264316A1 (en) 2020-11-26
WO2015123315A1 (en) 2015-08-20
US12566186B2 (en) 2026-03-03
SI3105592T1 (sl) 2019-02-28
CA2939080A1 (en) 2015-08-20
US11927596B2 (en) 2024-03-12
CY1121341T1 (el) 2020-05-29
EP3105592A1 (en) 2016-12-21
US20150226758A1 (en) 2015-08-13
PL3105592T3 (pl) 2019-04-30
US20180088140A1 (en) 2018-03-29
MX2016010413A (es) 2016-11-30
US11215623B2 (en) 2022-01-04
EP3422001B1 (en) 2020-03-25
CN106164670A (zh) 2016-11-23
EP3105592B1 (en) 2018-10-17
US20240288454A1 (en) 2024-08-29
CN106164670B (zh) 2019-06-14
EP3667321A1 (en) 2020-06-17
SG10201906750XA (en) 2019-09-27
EP4582812A3 (en) 2025-10-22
RS58212B1 (sr) 2019-03-29
US20220187327A1 (en) 2022-06-16
LT3105592T (lt) 2019-01-25
HUE041669T2 (hu) 2019-05-28

Similar Documents

Publication Publication Date Title
MX2016010413A (es) Ensayos para detectar la presencia o la cantidad de un anticuerpo antifarmaco.
PH12019501146A1 (en) Radiolabeled anti-pd-l1 antibodies for immuno-pet imaging
AU2018200278B2 (en) Antibodies to aripiprazole and use thereof
MX2025004620A (es) Anticuerpos anti-lag3 radiomarcados para la obtencion de imagenes mediante inmuno-pet
EP4464797A3 (en) Kit, device, and method for detecting lung cancer
MA40390A (fr) Procédés d'analyse impliquant des nanoparticules dissociables
MX2015012823A (es) Ensayo de combinacion de antigeno-anticuerpo del virus de la hepatitis c (vhc) y metodos y composiciones para usarlo.
BR112016019836A2 (pt) método para analisar uma amostra de um sujeito, dispositivo de diagnóstico para utilização no diagnóstico da endometriose, kit, uso de um biomarcador, e, método para aumentar uma resposta de anticorpos em um sujeito
MX2016013261A (es) Metodo para la cuantificacion de huevos de parasitos en las heces.
EP3933406A3 (en) Antibodies to risperidone and use thereof
MX2016001573A (es) Ensayos para timp2 con mejor rendimiento en muestras biológicas.
EA201792289A1 (ru) Способы обнаружения агглютинации и композиции для их осуществления
MX2019000592A (es) Dispositivo dispensador de reactivos analiticos liquidos, y kits analiticos y metodos de uso relacionados.
SA518391028B1 (ar) Cd37 أجسام مضادة واختبارات للكشف عن
MX2019011702A (es) Ensayos de inmunogenicidad mejorados.
SG10201806729VA (en) Novel assay to detect human periostin
EP3207374A4 (en) Method and system for determining the concentration of an analyte in a fluid sample
EP3922983A3 (en) Improved low sample volume urinalysis assay strip, analytical kits, and methods of use related thereto
SG10201901836PA (en) Test strip assembly
MY192159A (en) Method for detecting neutralizing antibodies against recombinant human insulin in human serum
GB2541596A (en) Method and composition for determining specific antibody responses to species of filovirus
SG10201809158TA (en) Device and method for detecting blood group antigens by means of an incomplete antibody
MX2017008748A (es) Ensayo para detectar dipeptidil peptidasa iv (dpp-4) humana.
MY175630A (en) Kit for measuring titer of a protein comprising human fc using indirect elisa and method for measuring titer of a protein comprising human fc using the same
HK1225791A1 (zh) 用於诊断的细胞表面前列腺癌抗原